Antitrust Antitrust

Pharma antitrust guidelines set for public review in China

China's antitrust regulator will soon release for public consultation a new set of guidelines for the pharmaceutical industry, reinforcing its oversight of sectors closely tied to public well-being.
 
The State Administration for Market Regulation, SAMR, expects to solicit public opinions on the draft rulebook "in the near future," the authority

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News